Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Follow-Up Study to Evaluate the Safety and Clinical Outcomes of Patients With Non-Malignant Disease Who Have Undergone Hematopoietic Stem Cell Transplantation With MGTA-456

NCT04008849 is registered in ClinicalTrials.gov with Magenta Therapeutics, Inc. as lead sponsor.

NCT NCT04008849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04008849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Follow-Up Study to Evaluate the Safety and Clinical Outcomes of Patients With Non-Malignant Disease Who Have Undergone Hematopoietic Stem Cell Transplantation With MGTA-456
Lead sponsor
Magenta Therapeutics, Inc.
Phase
Observational
Overall status
Terminated
Start date
May 21, 2019
Completion date
October 8, 2020
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inherited metabolic disorders (imd)